Adir Aronovich

Array ( [id] => 3886609 [patent_doc_number] => 05776952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Method and composition for topical therapy of back pain and muscle tension' [patent_app_type] => 1 [patent_app_number] => 8/682352 [patent_app_country] => US [patent_app_date] => 1996-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776952.pdf [firstpage_image] =>[orig_patent_app_number] => 682352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983831 [patent_doc_number] => 05861399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Methods and compositions for the rapid and enduring relief of inadequate myocardial function' [patent_app_type] => 1 [patent_app_number] => 8/680684 [patent_app_country] => US [patent_app_date] => 1996-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8332 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861399.pdf [firstpage_image] =>[orig_patent_app_number] => 680684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811404 [patent_doc_number] => 05770227 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Progesterone replacement therapy' [patent_app_type] => 1 [patent_app_number] => 8/682200 [patent_app_country] => US [patent_app_date] => 1996-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770227.pdf [firstpage_image] =>[orig_patent_app_number] => 682200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699002 [patent_doc_number] => 05677341 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Emulsion suitable for administering a sphingolipid' [patent_app_type] => 1 [patent_app_number] => 8/680993 [patent_app_country] => US [patent_app_date] => 1996-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2447 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677341.pdf [firstpage_image] =>[orig_patent_app_number] => 680993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689013 [patent_doc_number] => 05696168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Treatment of attention-deficit/hyperactivity disorder' [patent_app_type] => 1 [patent_app_number] => 8/682040 [patent_app_country] => US [patent_app_date] => 1996-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2507 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696168.pdf [firstpage_image] =>[orig_patent_app_number] => 682040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3788081 [patent_doc_number] => 05840744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Intravaginal treatment of vaginal infections with buffered metronidazole compositions' [patent_app_type] => 1 [patent_app_number] => 8/680750 [patent_app_country] => US [patent_app_date] => 1996-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14146 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840744.pdf [firstpage_image] =>[orig_patent_app_number] => 680750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793440 [patent_doc_number] => 05726202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Benign prostatic hypertrophy' [patent_app_type] => 1 [patent_app_number] => 8/678275 [patent_app_country] => US [patent_app_date] => 1996-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2210 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726202.pdf [firstpage_image] =>[orig_patent_app_number] => 678275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793029 [patent_doc_number] => 05780446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Formulations of vesicant drugs and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/700742 [patent_app_country] => US [patent_app_date] => 1996-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 62 [patent_no_of_words] => 17586 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780446.pdf [firstpage_image] =>[orig_patent_app_number] => 700742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886657 [patent_doc_number] => 05776955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents' [patent_app_type] => 1 [patent_app_number] => 8/676608 [patent_app_country] => US [patent_app_date] => 1996-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17871 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776955.pdf [firstpage_image] =>[orig_patent_app_number] => 676608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689518 [patent_doc_number] => 05691370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => '5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/675745 [patent_app_country] => US [patent_app_date] => 1996-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10857 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691370.pdf [firstpage_image] =>[orig_patent_app_number] => 675745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3735691 [patent_doc_number] => 05698537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Method of lowering the viscosity of mucus' [patent_app_type] => 1 [patent_app_number] => 8/666631 [patent_app_country] => US [patent_app_date] => 1996-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2464 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698537.pdf [firstpage_image] =>[orig_patent_app_number] => 666631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3736635 [patent_doc_number] => 05698594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Treatment and prevention of risk factors for cardiovascular diseases' [patent_app_type] => 1 [patent_app_number] => 8/660331 [patent_app_country] => US [patent_app_date] => 1996-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5066 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698594.pdf [firstpage_image] =>[orig_patent_app_number] => 660331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3877491 [patent_doc_number] => 05747509 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method for lowering plasma levels of lipoprotein(a)' [patent_app_type] => 1 [patent_app_number] => 8/657237 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5522 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747509.pdf [firstpage_image] =>[orig_patent_app_number] => 657237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3839899 [patent_doc_number] => 05744463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Treatment of side effects of progestins and progesterone analogues used for birth control' [patent_app_type] => 1 [patent_app_number] => 8/656737 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3140 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744463.pdf [firstpage_image] =>[orig_patent_app_number] => 656737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825940 [patent_doc_number] => 05731326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'PDGF antagonists II' [patent_app_type] => 1 [patent_app_number] => 8/657470 [patent_app_country] => US [patent_app_date] => 1996-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6416 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 374 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731326.pdf [firstpage_image] =>[orig_patent_app_number] => 657470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3788047 [patent_doc_number] => 05736574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Pharmacceutical/cosmetic compositions comprising synergistic antimicrobial admixture' [patent_app_type] => 1 [patent_app_number] => 8/649192 [patent_app_country] => US [patent_app_date] => 1996-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2180 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736574.pdf [firstpage_image] =>[orig_patent_app_number] => 649192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787670 [patent_doc_number] => 05840719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Apoptosis inhibitors for treating neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/556974 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 4985 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840719.pdf [firstpage_image] =>[orig_patent_app_number] => 556974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729036 [patent_doc_number] => 05703118 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Use of benzopyran derivatives for the treatment of pathologies associated with the NA.sup.+ -independent CI-/HCO.sub.3 -exchanger' [patent_app_type] => 1 [patent_app_number] => 8/643257 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4083 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/703/05703118.pdf [firstpage_image] =>[orig_patent_app_number] => 643257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724300 [patent_doc_number] => 05681823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'P.sup.1, P.sup.4 -dithio-P.sup.2 -P.sup.3 -monochloromethylene 5\', 5\'\"-diadenosine P.sup.1, P.sup.4 -tetraphosphate as antithrombotic agent' [patent_app_type] => 1 [patent_app_number] => 8/643029 [patent_app_country] => US [patent_app_date] => 1996-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10861 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681823.pdf [firstpage_image] =>[orig_patent_app_number] => 643029 [rel_patent_id] =>[rel_patent_doc_number] =>)